Ex-Nycomed chief to take chairman's seat at Lundbeck

Hâkan Björklund--Courtesy of Lundbeck

Lundbeck board member Hâkan Björklund will step into the chairman's job when Mats Pettersson steps down next month. Björklund had been CEO at the Swiss drugmaker Nycomed, until it sold out to Takeda Pharmaceutical in 2011. Lundbeck is in the midst of rebuilding after losing patent protection on its biggest-selling drug, Cipralex. Release | Report

Suggested Articles

Researchers scoured the database where pharma companies disclose payments made to physicians and discovered a troubling trend.

Just a few months after playing a pivotal role in Sanofi’s Bioverativ buy, Alex Denner has set his sights on Ironwood.

Clovis' new approval will boost Rubraca in recurrent ovarian cancer, but because of its competitors' head start, the race will be tough.